SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-24-011246
Filing Date
2024-04-05
Accepted
2024-04-05 17:29:07
Documents
4
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A vtgn20240402_pre14a.htm PRE 14A 676811
2 a01.jpg GRAPHIC 7653
3 capvsnl.jpg GRAPHIC 23609
4 capvstsr.jpg GRAPHIC 25531
  Complete submission text file 0001437749-24-011246.txt   756599
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 001-37761 | Film No.: 24827573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)